Daliap, Erwan B.
HRN: 22-72-70 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2024
CEFUROXIME 750MG (VIAL)
08/07/2024
08/14/2024
IV
670 MG IVTT
EVERY 8 HOURS
ACUTE TONSILLOPHARYNGITIS
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes